July 2024

PULMONARY

LUNG DISEASE IS FOCUS OF NEW NIH GRANT

Featuring: Benjamin Singer, MD

​A new $12 million National Institutes of Health grant led by Northwestern Medicine scientists in collaboration with other institutions will fund studies to identify mechanisms that determine how lung neutrophils drive tissue injury, inflammation and repair in patients with severe pneumonia, lung transplantation and asthma. Neutrophils are cells involved in lung inflammation and injury, but also repair.

“Neutrophils have been understudied and are not well understood,” said co-grant leader Benjamin Singer, MD, an associate professor of Medicine in the Division of Pulmonary and Critical Care. “We want to understand the biology of this cell type within the context of patients’ lung diseases and their immune systems.”

The grant — “The Neu-Lung Consortium: Neutrophilic Mechanisms of Inflammation, Injury, and Repair in Lung and Airways Diseases” — is part of the National Institute of Allergy and Infectious Diseases’ U19 Cooperative Centers in Human Immunology.  Northwestern is one of five sites chosen for this award. In addition to Singer, the grant is led by Stephanie Eisenbarth, MD, PhD, chief of allergy and immunology and director of the Center for Human Immunobiology at Feinberg, and Alexander Misharin, MD, PhD, associate professor of Medicine in the Division of Pulmonary and Critical Care.
​
Other investigators are from Ann & Robert H. Lurie Children’s Hospital of Chicago, National Jewish Health in Denver, the University of Colorado Children’s Hospital in Denver, and the University of Calgary in Canada.
​
​
​This article was originally published in the Feinberg School of Medicine News Center on July 30, 2024. 
Benjamin Singer, MD, an associate professor of Medicine in the Division of Pulmonary and Critical Care.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like